Serum Levels of Factor XIII, D-dimer, and Fibrinogen as A non-Invasive Diagnostic Biomarkers in Patients with Venous Thromboembolism
سال انتشار: 1403
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 113
فایل این مقاله در 9 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_ZUMS-32-154_004
تاریخ نمایه سازی: 23 دی 1403
چکیده مقاله:
Background & Objective: Using new diagnostic methods to help quickly diagnose VTE disease is important. It is well known that treatment of VTE is based on radiological methods, but the main purpose of this research was to investigate the relationship between blood coagulation factor XIII( FXIII), D-dimer, and fibrinogen levels in patients with VTE.
Materials & Methods: Seventy patients initially suspected of having VTE were included and determined their D-dimer, fibrinogen, and (FXIII )levels. The diagnosis of VTE was based on the CT-Angiography. The blood samples were prepared from the patients during the first ۶ hours of admission and before using anticoagulant.
Results: The mean level of D-dimer in VTE patients was higher than those without VTE (۱۷۷۰± ۷۶۴.۴۹ vs. ۴۳۰.۶۶± ۲۶۳.۹۸ng / ml) (p <۰.۰۰۱). The mean factor XIII level in patients with VTE was significantly lower than those without VTE(۵۵.۰۳±۱۳.۶۱ vs. ۸۸.۵۷±۱۸.۱۴ng / ml) (p <۰.۰۰۱). The mean fibrinogen level in patients with VTE was significantly lower than in non-VTE patients (۱۴۰.۴۹± ۳۶.۰۳ vs. ۲۱۴.۶۹± ۶۹.۷۳ mg/dl) (p <۰.۰۰۱). The cut-off value of D-dimer was ۵۰۰ ng/ml, and the sensitivity and specificity were ۹۷% and ۷۴%, respectively. The cut-off point of fibrinogen was ۱۶۸ mg/dl, with a sensitivity of and a specificity of ۷۷% and ۷۷%, respectively. The cut-off point of XIII was ۷۰ ng/ml, with a sensitivity of and specificity۸۵% and ۸۲%, respectively.
Conclusion: Our findings suggest that combined measurement of serum levels of D-dimer, factor XIII, and fibrinogen can be used to confirm clinical suspicion for VTE.
کلیدواژه ها:
نویسندگان
Mahmoud Monadi
Clinical Research Development Unite of Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran
Mohammad Ranaee
Cancer Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
Hossein Omranpour Bandpey
Dept. of Internal Medicine, School of Medicine, Babol University of Medical Sciences, Babol, Iran
Durdi Qujeq
Cellular and Molecular Biology Research Center (CMBRC), Health Research Institute, Babol University of Medical Sciences, Babol, Iran
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :